HEATHER FORD: Open Payments
NPI 1174165054 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 45 payments from 11 companies in 2025. Trend: 2023 $42 · 2024 $869 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $216 |
| Vanda Pharmaceuticals Inc. | 9 | $154 |
| E.R. Squibb & Sons, L.L.C. | 4 | $149 |
| Neurocrine BioSciences, Inc. | 6 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Tris Pharma Inc | 1 | $25 |
Products named: VRAYLAR, COBENFY, HETLIOZ, INGREZZA, REXULTI, CAPLYTA, UZEDY, SPRAVATO.
Industry payments across SC — which companies pay providers there.
